SPRY

About ARS Pharmaceuticals, Inc. Common Stock (SPRY) Stock

ARS Pharmaceuticals, Inc. Common Stock (SPRY) closed the 2026-09-17 session at $4.15, down 0.36% versus the previous close (-0.01). The stock opened at $4.26 and traded between $4.12 and $4.30 during that session. Session trading volume was 1.9M shares. The volume-weighted average price (VWAP) is $4.16.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

ARS Pharmaceuticals, Inc. Common Stock has a market capitalization of $414.2 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. SPRY is listed on the XNAS exchange. The company employs approximately 200 people. ARS Pharmaceuticals, Inc. Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2022-11-09.

On this page you can find market SPRY stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.